Status:
COMPLETED
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a single cohort observational safety study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the ...
Eligibility Criteria
Inclusion
- All patients who are considered candidates to receive Herceptin for this indication
Exclusion
- Patients for whom Herceptin is contraindicated
Key Trial Info
Start Date :
August 30 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2016
Estimated Enrollment :
3942 Patients enrolled
Trial Details
Trial ID
NCT01152606
Start Date
August 30 2007
End Date
May 31 2016
Last Update
January 25 2018
Active Locations (205)
Enter a location and click search to find clinical trials sorted by distance.
1
Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie
Graz, Austria, 8036
2
LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie
Graz, Austria, 8036
3
Lhk Klagenfurt; Abt. Für Gynäkologie
Klagenfurt, Austria, 9026
4
LKH Hochsteiermark; Abt. für Innere Medizin
Leoben, Austria, 8700